Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;185(8):2519-2525.
doi: 10.1002/ajmg.a.62344. Epub 2021 May 19.

COXPD9 in an individual from Puerto Rico and literature review

Affiliations
Review

COXPD9 in an individual from Puerto Rico and literature review

Hind Alsharhan et al. Am J Med Genet A. 2021 Aug.

Abstract

Defects of mitoribosome assembly with destabilization of mitochondrial ribosomal proteins and subsequent aberrant mitochondrial translation machinery are one of the emerging categories of human mitochondrial disease. Mitochondrial translation deficiency constitutes a growing cause of combined oxidative phosphorylation deficiency and overall causes a set of clinically heterogeneous multi-systemic diseases. We present here the sixth individual with combined oxidative phosphorylation deficiency-9 (COXPD9) secondary to a likely pathogenic homozygous MRPL3 variant c.571A > C; p.(Thr191Pro). MRPL3 encodes a large mitochondrial ribosome subunit protein, impairing the mitochondrial translation and resulting in multisystem disease. Similar to previously reported individuals, this reported female proband presented with psychomotor retardation, sensorineural hearing loss, hypertrophic cardiomyopathy, failure to thrive, and lactic acidosis. Further, she has additional, previously unreported, features including Leigh syndrome, cataracts, hypotonia, scoliosis, myopathy, exercise intolerance, childhood-onset cardiomyopathy, and microcephaly. This subject is the oldest reported individual with COXPD9. This report also summarizes the clinical and molecular data of the previously reported individuals with COXPD9 to describe the full phenotypic spectrum.

Keywords: MRPL3; cardiomyopathy; lactic acidosis; mitoribosome; translation.

PubMed Disclaimer

References

REFERENCES

    1. Baertling, F., Haack, T. B., Rodenburg, R. J., Schaper, J., Seibt, A., Strom, T. M., Meitinger, T., Mayatepek, E., Hadzik, B., Selcan, G., Prokisch, H., & Distelmaier, F. (2015). MRPS22 mutation causes fatal neonatal lactic acidosis with brain and heart abnormalities. Neurogenetics, 16, 237-240.
    1. Bamshad, M. J., Ng, S. B., Bigham, A. W., Tabor, H. K., Emond, M. J., Nickerson, D. A., & Shendure, J. (2011). Exome sequencing as a tool for Mendelian disease gene discovery. Nature Reviews. Genetics, 12, 745-755.
    1. Bugiardini, E., Mitchell, A. L., Rosa, I. D., Horning-Do, H. T., Pitmann, A. M., Poole, O. V., Holton, J. L., Shah, S., Woodward, C., Hargreaves, I., Quinlivan, R., Amunts, A., Wiesner, R. J., Houlden, H., Holt, I. J., Hanna, M. G., Pitceathly, R. D. S., & Spinazzola, A. (2019). MRPS25 mutations impair mitochondrial translation and cause encephalomyopathy. Human Molecular Genetics, 28, 2711-2719.
    1. Bursle, C., Narendra, A., Chuk, R., Cardinal, J., Justo, R., Lewis, B., & Coman, D. (2017). COXPD9 an evolving multisystem disease; congenital lactic acidosis, sensorineural hearing loss, hypertrophic cardiomyopathy, cirrhosis and interstitial nephritis. JIMD Reports, 34, 105-109.
    1. Carroll, C. J., Isohanni, P., Pöyhönen, R., Euro, L., Richter, U., Brilhante, V., Götz, A., Lahtinen, T., Paetau, A., Pihko, H., Battersby, B. J., Tyynismaa, H., & Suomalainen, A. (2013). Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein MRPL44 to underlie mitochondrial infantile cardiomyopathy. Journal of Medical Genetics, 50, 151-159.

MeSH terms